IASLC 2019 Latin America Conference on Lung Cancer (LALCA … · 2019-10-12 · LALCA2019.IASLC.ORG 3 IASLC 2019 Latin America Conference on Lung Cancer (LALCA 2019) | Final Scientiffc

IASLC 2019 Latin America Conference on Lung Cancer (LALCA 2019) | Final Scientific ProgramLALCA2019.IASLC.ORG

2

Announcing the launch of

A new open access journal from the IASLC

JTO Clinical and Research Reports is the official open access journal of the International Association for the Study of Lung Cancer. It aims to complement the Journal of Thoracic Oncology by offering authors a gold open access publication option and publishing the following article types in particular:

• Phase I trials

• Well performed single-armphase II trials

• Subset analyses of published trials

• Impactful retrospective studies

• Database analysis

• Large institutional series

• High-quality case reports

• Region-specific clinical trials

• Subspecialty thoracic oncology studies

• Selected high-quality meeting reports

LALCA2019.IASLC.ORG

3

IASLC 2019 Latin America Conference on Lung Cancer (LALCA 2019) | Final Scientific Program

3

Table of ContentsConference Sponsors

The IASLC 2019 Latin America Conference on Lung Cancer (LALCA 2019) would like to thank the following organizations for their generous support.

Conference Secretariat

International Conference Services Ltd. (ICS)Suite 300 - 1201 West Pender StreetVancouver, BC, Canada V6E 2V2Phone +1 604 681 2153Fax +1 604 681 1049www.icsevents.com

Welcome Message 4

International Association for theStudy of Lung Cancer (IASLC) 5

Conference Committees

International Committee 5 Local Organizing Committee 5 Latin American (LATAM) Committee 5

General Conference Information

Conference Venue incl. Floor Plans 6 Conference Registration 7 Networking Events 7 Information For Speakers and Abstract Presenters 8 Onsite Services and General Information 9 Press and Media 10

Exhibit Information

Exhibit Hours, Location and Events 12 Exhibit Floor Plan 12 Exhibitor Listings and Descriptions 13

Scientific Program

Program at a Glance 14-15 Thursday, October 17, 2019 16-19 Friday, October 18, 2019 19-21 Saturday, October 19, 2019 22-23

Poster Session Friday, October 18, 2019 24 Saturday, October 19, 2019 25

LALCA 2019 Travel Awards 26

Mexico City Information 27

Tours 28

Abstract Author Index 29-32

Platinum Level

Silver Level

Bronze Level

Other Sponsorship


4

Welcome MessageW

ELC

OM

E M

ESS

AG

E

Welcome to the IASLC 2019 Latin America Conference on Lung Cancer (LALCA 2019). Lung cancer is still the leading cause of cancer death not only in Latin America but worldwide. Building on the success of the previous conferences in Argentina, Panama, Peru and other countries, international and national speakers will discuss the science and advances in the treatment and prevention of lung cancer and other thoracic malignancies worldwide and Latin America in particular.

Simultaneous translation English >< Spanish will be provided for all sessions.

With tobacco being the leading cause of morbidity and mortality worldwide, the LALCA Conference will once again host a Cancer Control Program and Tobacco Forum on Thursday, October 17 (16:00 – 17:00). The inaugural “IASLC LALCA Advocacy Group Meeting” will take place as well on the same day (09:00 – 12:45), and will include presentations from scientists, patients and advocates.

This year, we will host again the IASLC School of Thoracic Oncology, an intense workshop for young researchers and clinicians as well as trainee physicians from different disciplines including medical oncology, thoracic surgery, radiation oncology, pulmonary, radiology and pathology. The workshop will take place on Thursday. Also, we will host the IASLC School of Nursing and IASLC School of Pathology that will help these healthcare professionals interact with worldwide experts in the field. We will have, in collaboration with GO2 Foundation, a lung cancer advocacy session during a Living Room where more than 40 patients will meet with lung cancer leaders to discuss the most important concerns regarding lung cancer therapy; this session will be streamed live in YouTube and Facebook.

We will also continue with the very successful Round Table Discussions providing delegates a unique opportunity to talk directly with international leaders and local experts on specific topics. A total of 10 different round table topics will be offered. Don’t miss this great opportunity and make sure to participate in the Round Table Discussions.

We also would like to highlight various symposia hosted by our industry sponsors. They are free of charge to all delegates and the presented topics will complement the scientific sessions of the LALCA Conference.

We also encourage you to visit our exhibitors and poster presenters in the Exhibit Hall. Poster presenters will be available during the morning and afternoon Networking Breaks to discuss their research work with you. Please note that a different set of posters will be displayed each day.

We are thrilled that you are joining us for a stimulating and exciting conference and hope you have the chance to take a little extra time to enjoy Mexico City. This beautiful city is located in the Valley of Mexico, and it is one of the oldest cities in the Americas, built on an island of Lake Texcoco by the Aztecs in 1325 AD. It is a popular destination for many foreign tourists as it is steeped in rich history. Famous landmarks in the historic center

include the Plaza de la Constitución (Zócalo), the main central square, and ancient Aztec temple ruins Templo Mayor, all of which are situated among many modern architectural structures.

Mexico City is also renowned for some of the world’s best gastronomy. In 2018, two Mexico City restaurants made it to the World’s Top 50 list of best restaurants including Quintonil (# 11) and Pujol (# 13). Don’t miss your chance to experience all that Mexico City has to offer!

We look forward to welcoming you to Mexico City and to the IASLC LALCA 2019 Conference!

Oscar G. ArrietaLocal Conference Chair

Luis E. RaezLATAM Group Chair & Scientific Chair

Edgardo S. SantosInternational Conference Chair

LALCA2019.IASLC.ORG

5


5

Chair:Oscar G. Arrieta, Mexico

Co-Chairs: Saul Campos, MexicoFernando Aldaco, Mexico

Chair Emeritus: Jaime G De La Garza, Mexico

Scientific Chair: Luis E. Raez, USA

Educational IASLCSchool of Oncology Chair:Christian Rolfo, USA

International Chair:Edgardo S. Santos, USA

International Committee

MEMBERS:

Tetsuya Mitsudomi, JapanIASLC President

Heather A. Wakelee, USAIASLC President-Elect

Giorgio Scagliotti, ItalyIASLC Past-President

María Arcila, USAPaul A. Bunn Jr., USAAlberto Chiappori, USADavid R. Gandara, USAJorge Gómez, USAFred R. Hirsch, USATiciana Leal, USALuis Paz-Ares, SpainDelvys Rodríguez, SpainRafael Rossell, SpainMarileila Varella-Garcia, USAIgnacio Wistuba, USACamilla Zimmerman, Canada

Local Organizing Committee

MEMBERS:

Medical OncologyFernando AldacoOscar ArrietaLuis Martínez BarreraFeliciano BarrónYolanda BautistaJosé Rogelio González Ramírez Benfield Carolina BlancoSaul Campos

Jerónimo Rodríguez CidJaime de la GarzaRaquel Gerson Cesar GonzálezDavid HortaManuel MagallanesVanesa MontesGilberto MorganMario PérezMarcelino Ramírez Iván Romarico Manuel SeguraRogelio TrejoJuan Zinser

PathologyHoracion Astudillo Federico Maldonado ÁvilaAlejandro AvilésIsabel Alvarado Cabrero Cesar Lara Cesar Luna RiveroSergio Sánchez Sosa

Radiation TherapyMónica BlakeDolores de la Mata Moya Cuauhtémoc de la PeñaJosé Hinojosa GómezFederico Maldonado Julia Sáenz

Thoracic SurgeryErick BazanAndrés BlancoFrancisco Corona CruzWalid Dajer Fadel Enrique Guzmán de Alba Carlos Ibarra Pérez Marco Antonio IñiguezEdgardo JiménezFrancisco Osvaldo Gregorio Quintero Benitos Vargas

PneumologyMarisol ArroyoRenata BáezElma Correa Rogelio Pérez Padilla Adrián Rendon PérezOlivia Sánchez Interventional RadiologyJorge Guerrero

Palliative CareSilvia AllendeRoció GuillenUsebio Pérez

NutritionYolanda Barretero Dana Pérez Camargo Carla SánchezJenny G. Turcott

Pulmonary RehabilitationLuis Torre

NursingEnza Esposito-NguyenLavinia Dobrea

Latin American (LATAM) Committee

MEMBERS:

Alfredo Aguilar, PerúEric Arauz, PanamáClarisa Baldotto, BrazilCarlos Barrios, BrazilChristian Caglevic, Chile Andrés Cardona, ColombiaCarlos Carracedo, PerúGilberto Castro, BrazilHugo Castro, GuatemalaLuis Corrales, Costa RicaAlejandro Crismatt, PanamáLiliana Dalurzo, ArgentinaLucia Delgado, ArgentinaGustavo Ferraris, ArgentinaCarlos Gil Ferreira, Brazil Graciela Gómez, ParaguayDiego Kaen, ArgentinaRoberto Iván López, PanamáJorge Madrid, ChileClaudio Martin, ArgentinaLuis Mas, PerúGeorge Oblitas, PerúClarissa Mathias, BrazilHéroes Morales, GuatemalaFrancisco Orlandi, ChileNorma Pilnik, ArgentinaEduardo Richardet, ArgentinaMartin Richardet, ArgentinaTatiana Vidaurre Rojas, PerúRossana Ruiz, PerúMoises Russo, ChileRoberto Salinas, El SalvadorRicardo Santos, BrazilClaudio Sola, ChileRicardo Terra, BrazilLuis Ubillos, UruguayCarlos Vallejos, PerúMario Varangot, UruguayIgnacio Veliz, PanamáRuth Vergara, PanamáLucia Viola, ColombiaWilliam William, Brazil Nise Yamaguchi, Brazil

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association’s membership includes more than 7,500 lung cancer specialists in over 100 countries.

International Association for the Study of Lung Cancer13100 East Colfax Avenue, Unit 10Aurora, Colorado, USA 80011Phone: +1 855-GO-IASLC (+1 855 464 2752)www.iaslc.org

IASLC

Conference Committees


6

GE

NE

RA

L C

ON

FER

EN

CE

INFO

RM

ATI

ON


CONFERENCE VENUE

The IASLC 2019 Latin America Conference on Lung Cancer (LALCA 2019) is being held at the InterContinental Presidente. All Session Rooms (Castillo A, Castillo B and Feria) and the Exhibit Hall are located on the 4th Floor of the Hotel. The Registration Desk is located on the Mezzanine Floor.

InterContinental PresidenteCampos Eliseos 218, Chapultepec PolancoDel. Miguel Hidalgo: Ciudad de Mexico, CMS11560, MexicoTel: +52.55.53277700

4th Floor - Castillo Level

Mezzanine Floor

FLOOR PLAN

3th Floor - Aztlan Level

Upstairs

Upstairs

Downstairs

WCHombres

WCMujeres

Feria 1 Feria 2 Feria 3

Flores Fuentes Bosques Elevator WC ElevatorServiceElevator

Warehouse

MSDHOSPITALITY

SUITE

MEETINGORGANIZER

OFFICE

SPEAKERREADYROOM

IASLCOFFICE

CastilloA1 - 4

SESSIONROOM 1

CastilloB

EXHIBIT HALL &POSTER DISPLAY

CastilloA5 - 6

SESSIONROOM 2

Comes fromUxmal -

Coba Level

Goes toUxmal -

Coba Level

PRESSROOM

LALCA2019.IASLC.ORG

7


7

GE

NE

RA

L CO

NFE

RE

NC

E IN

FOR

MA

TION

CONFERENCE REGISTRATION

The Registration Desk is located in the foyer area by the escalators on the Mezzanine Floor of the InterContinental Presidente.

Registration Desk Hours

Wednesday, October 16 14:00 – 20:00

Thursday, October 17 07:00 – 20:00

Friday, October 18 06:30 – 17:30

Saturday, October 19 07:30 – 16:00

Name BadgesAttendees are requested to wear their name badges at all times in order to participate in the Scientific Sessions and Exhibition. A 50 USD fee applies for any name badge reprints due to lost name badges.

NETWORKING EVENTS

Welcome Reception

Thursday, October 17 – 19:30 – 20:00

InterContinental Presidente, Exhibit Hall, 4th Floor

Faculty Dinner

Friday, October 18 – 20:00 – 23:00

By invitation only, please check for your invitation in your registration

badge holder.

Poster Viewing & Networking Breaks(Snacks and refreshments provided)

Friday, October 18 09:30 – 10:30 & 15:15 – 16:15

Saturday, October 19 10:00 – 11:00 InterContinental Presidente, Exhibit Hall, 4th Floor

IASLC Foundation RELAUNCH!The IASLC Foundation has taken on a new name and a new look!

The International Lung Cancer Foundation (ILCF) has adopted a striking new look to inspire confidence in our mission. Please join us on our journey and

thank you to all who have continued to support us. Together we will fight to conquer thoracic malignancies!

For more information please visit: IASLC.org/ILCF

I N S P I R I N G H O P E T H R O U G H R E S E A R C H


8

GE

NE

RA

L C

ON

FER

EN

CE

INFO

RM

ATI

ON

INFORMATION FOR SPEAKERS AND ABSTRACT PRESENTERS

Invited Speakers and Oral PresentersAll speakers are asked to be in the session room at least 15 minutes prior to the start of their session.

Please provide your presentation slides to the Speaker Ready Room, in room Bosques on the 4th Floor at least 24 hours prior to your presentation, or as of the opening hours on Wednesday, October 16. The use of personal laptops for presentations is not allowed as it can cause technical delays and cut into a presenter’s time.

Speaker Ready Room Hours

Wednesday, October 16 15:00 – 20:00




Poster Presenters

All Poster Presentation boards are located in the Exhibit Hall on the 4th Floor of the InterContinental Presidente.

Each Poster Board is identified with a Poster Number that corresponds with the pre-assigned Poster Number published on the Conference website, in this Program Book as well as in the Abstract Book.

Different set of posters will be displayed each day. Each poster presentation will be on display for the entire day with an author standby time during each day’s morning and afternoon Poster Viewing and Networking Break. Poster presenters are required to stand by their poster during the designated times to answer questions from delegates.

Poster Session 1 Friday, October 18

Poster Set Up Time: 08:00 – 08:30Poster Take Down Time: 18:30 – 19:00

Poster Display Time: 08:30 – 18:30Author Standby Time: 09:30 – 10:30 & 15:15 – 16:15 (Networking Breaks)

Topics for Poster Session 1 • Prevention, Early Detection, Epidemiology and Tobacco

Control• SCLC, Mesothelioma, Thymoma• Biology and Pathogenesis• Bronchoscopy• Nursing & Allied Health

Poster Session 2Saturday, October 19

Poster Set Up Time: 08:00 – 08:30Poster Take Down Time: 16:30 – 17:00

Poster Display Time: 08:30 – 16:30Author Standby Time: 10:00 – 11:00 (Networking Break)

Topics for Poster Session 2• Early Stage NSCLC (Stage I – III)• Advanced NSCLC• Pathology• Immunotherapy

Tape will be provided to attach the posters to the board.


LALCA2019.IASLC.ORG

9


9

ONSITE SERVICESAND GENERAL INFORMATION

Abstract Book All accepted abstracts will be available online on the Journal of Thoracic Oncology website following the Conference. For those delegates who expressed their preference to receive a printed abstract book, they will be available at the Registration Desk.

Certificate of AttendanceDelegates can download their ‘Certificate of Attendance’ after completing the online Conference evaluation form available via the following website (https://icsevents.eventsair.com/lalca2019/evaluation) as of Saturday, October 19.

Mexican Accreditation The following societies are in support of member participation at the IASLC 2019 Latin America Conference on Lung Cancer (LALCA 2019). The Mexican Society of Pneumology and Cardiothoracic Surgery - “Sociedad Mexicana de Neumología y Tórax (SMNyCT)” and the Mexican College and Association of Pathologists - “Colegio y Asociación Mexicana de Patólogos (CAMP)” will provide medical residents who attend the meeting re-certification points according to their speciality. The LALCA 2019 ‘Certificate of Attendance’ must be submitted post conference to the appropriate society directly, in order for the points to be awarded.

Networking BreaksOn the Conference days, refreshments will be available in the Exhibit Hall during the scheduled morning and afternoon Networking Breaks.

Simultaneous TranslationThe official Conference language is English; however, presentations can be given in Spanish and simultaneous English and Spanish translation will be provided for all Scientific Sessions and some Industry Symposia. Presentation slides must be in ENGLISH.

A personal photo ID is required to receive a wireless receiver for simultaneous translation.

Lost and Found / MessagesLost and found items should be returned/claimed at the Registration Desk.

Wi-FiWi-Fi will be provided in the meeting space area. Please check your registration badge for details.

Mobile AppDownload the free official mobile app “LALCA 2019” for a convenient way to stay up-to-date via your phone or tablet. View the full scientific schedule, abstracts, exhibit information including floor plan and exhibitor biographies, and general Conference and venue information on our easy to use app! The app is compatible with all iOS devices (iPhone, iTouch and iPad) and all Android mobile devices. Timely updates on program or room changes will be distributed through the mobile app via notification alerts.

Lactation / Prayer RoomOn Friday, October 18 and Saturday, October 19, room Tulum, located on the 3rd Floor will be assigned as the Lactation Room / Prayer Room. The room will be open for sign-up from 08:30 – 19:00 on Friday and 08:30 – 16:30 on Saturday.

Nursing / First AidContact the Hotel concierge for First Aid by the Security and Prevention Department. The InterContinental Presidente also has a contact with the Hospital Español located in 10 minutes distance from the Hotel (Address: Av Ejército Nacional 613, Granada, 11520 Ciudad de México, CDMX).

Emergency and SafetyDial 911 for police, 066 for an ambulance and 080 for fire services. Please have the number of your embassy with you when traveling. In case of fire at the Hotel, use the stairs and NOT the elevator for exit. Please follow the Hotel’s instructions in case of emergency.

Conference EvaluationAn online Conference evaluation form will be available at https://icsevents.eventsair.com/lalca2019/evaluation as of Saturday, October 19. Please help us to improve the Conference by filling out the survey. Thank you for your support!

GE

NE

RA

L CO

NFE

RE

NC

E IN

FOR

MA

TION


10

GE

NE

RA

L C

ON

FER

EN

CE

INFO

RM

ATI

ON


PRESS AND MEDIA

Press and Media AccessPre-registered Press and Media representatives are required to check in at the Registration Desk. Non-registered Press and Media representatives should also proceed to the Registration Desk and need to provide their press/media credentials to receive a Press/Media badge.

Press InterviewsPress interviews with doctors and local patients will be taking place in the Exhibit Hall. Please visit the Registration Desk for further guidance.

Use of LALCA Scientific Program ContentPlease be aware that the information and materials displayed and/or presented at all sessions of this meeting are the property of the IASLC 2019 Latin America Conference on Lung Cancer and cannot be photographed, copied, photocopied, transformed to electronic format, reproduced or distributed without the written permission of the International Association for the Study of Lung Cancer (IASLC). Use of the LALCA/IASLC name and/or logo in any fashion by any commercial entity for any purpose is expressly prohibited without the written permission of the International Association for the Study of Lung Cancer.

LALCA2019.IASLC.ORG

11


11

MEMBERSHIP OFFER We’re more than 7,500 strong! Won’t you join us? Take advantage of this great value now!

Here are just some of the benefits you’ll receive when you become an IASLC member:

• Member access to the Journal of Thoracic Oncology

• Discounts to the IASLC World Conference on Lung Cancer and other scientific meetings

• Opportunity to make an impact by participating on IASLC member committees

• Access to the IASLC member directory

To learn more about levels of membership and benefits, visit: www.iaslc.org/membership.

JOIN THE IASLC

TODAY!

New Members OnlyWCLC Special Offer – Join during the WCLC and get two years for the price of one. Your membership starts immediately and doesn’t

end until December 31, 2021.

WCLC NEW Regular Member:

US $250.00

WCLC NEW Developing Country

Member: US $50.00

WCLC NEW Allied Professional

Member: US $50.00

WCLC NEW Fellow/Resident/Trainee

Member: Free

WCLC NEW Patient/Survivor/Caregiver

Member: Free


12

3 4

5 62

1

EX

HIB

IT IN

FOR

MA

TIO

N

Exhibit Information

EXHIBIT FLOOR PLAN

International Association for the Study of Lung Cancer (IASLC)

Amgen

Beacon

Merck

A Breath of Hope Lung Foundation

Biocept

EXHIBIT LOCATION

The LALCA 2019 Exhibition is held in the Foyer located on the 4th Floor of the InterContinental Presidente.

Exhibit Hours

Thursday, October 17 19:30 – 21:30 (Welcome Reception)



EXHIBIT EVENTS & HIGHLIGHTS

Welcome Reception


Inclusive with full conference registration. Additional tickets for friends and guests are available at 50 USD and can be purchased at the Registration Desk (by credit card only).

Exhibits are an integral part of the experience at LALCA 2019. The Exhibition opens on Thursday, October 17 at 19:30 with the Welcome Reception. Enjoy local wines and hors d’oeuvres, allowing you the opportunity to mix and mingle with exhibitors, colleagues and friends.

Networking BreaksOn Friday, October 18 and Saturday, October 19, refreshments are available for registered delegates in the Exhibit Hall during the morning and afternoon Networking Breaks.

Friday, October 18 09:30 – 10:30 & 15:15 – 16:15


Poster SessionsThe Poster Sessions are an important educational part of this meeting. All poster presentations are located in the Exhibit Hall. All poster presentations have been assigned a consecutive publication number for locating the abstract/poster in this Program Book and the Abstract Book which corresponds to the Poster Board Numbers.

For further details regarding Poster display and author stand by times, please refer to page 24-25 in this Program Book.

LALCA2019.IASLC.ORG

13


13

EX

HIB

IT INFO

RM

ATIO

N

EXHIBITORCOMPANY DESCRIPTIONS

A Breath of Hope Lung FoundationA Breath of Hope Lung Foundation, headquartered in Minnesota, works to improve lung cancer outcomes through research, public awareness, and patient education and support. ABOH has awarded $1.5 million in U.S. research funding and screening grants and provides an online animated patient guide to lung cancer in English/Spanish at youandlungcancer.com.

AmgenAmgen is committed to the relentless pursuit of breakthroughs for cancer patients and their families. We are developing innovative medicines for difficult-to-treat cancers and advancing the largest pipeline of cancer therapies in our history. Our goal is to quickly advance new treatment options with the greatest potential benefit to patients.

BeaconBEACON Medicare Limited is a concern of BEACON Group and Global Marketing Partner of BEACON Pharmaceuticals Limited. BEACON is the No-1 Oncology company and one of the leading pharma companies of Bangladesh. BEACON manufactures more than 150 lifesaving anti-cancer products which includes conventional chemotherapy, Monoclonal antibodies, Targeted therapies, Nano and Liposomal preparations. After meeting the local demand, BEACON exports its medicines globally.

BioceptBiocept, Inc. is a molecular diagnostics company with commercialized assays for lung, breast, gastric, colorectal and prostate cancers, and melanoma. The Company uses its proprietary liquid biopsy technology to provide physicians with clinically actionable information for treating and monitoring patients diagnosed with cancer. The Company’s patented Target Selector™ liquid biopsy technology platform captures and analyzes tumor-associated molecular markers in both circulating tumor cells (CTCs) and in circulating tumor DNA (ctDNA). For additional information, please visit www.biocept.com.

International Association for theStudy of Lung Cancer (IASLC)

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association’s membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit iaslc.org for more information.

MerckFor more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Today, MSD continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases around the world.


14

PR

OG

RA

M A

T A

GLA

NC

E

Program at a Glance

07:00

07:30

08:00

08:30

09:00

09:30

10:00

10:30

11:00

11:30

12:00

12:30

13:00

13:30

14:00

14:30

15:00

15:30

16:00

16:30

17:00

17:30

18:00

18:30

19:00

19:30

20:00

20:30

21:00

21:30

Thursday, October 17, 2019

Castillo A 1-2

IASLC School ofThoracic Oncology

09:00 - 15:15

Release of Special Issue Session17:00 - 18:00

IASLC School ofPathology

08:15 - 15:30IASLC School ofNursing

09:00 - 15:30

IASLC AdvocacyGroup Meeting09:00 - 12:45

IASLC Lung CancerLiving Room13:00 - 15:00

Livestream and Overflow Room for IASLC Lung Cancer

Living Room13:00 - 15:00

Castillo A 3-4 Castillo A 5-6 Feria 2-3 Castillo B3 Exhibit Hall(Foyer)

Welcome Reception19:30 - 20:00

IndustrySymposium

220:00 - 21:30

Cancer ControlProgram and

Tobacco Forum16:00 - 17:00

LATAM GeneralGroup Meeting

18:00 - 18:45

Opening Ceremony18:45 - 19:30

Lung CancerScreening

17:00 - 18:00

IndustrySymposium

120:00 - 21:30

LALCA2019.IASLC.ORG

15


15

PR

OG

RA

M A

T A G

LAN

CE

Friday, October 18, 2019

Feria 2-3Castillo A 1-4 Castillo A 5-6 Exhibit Hall(Foyer)

Session 108:30 - 09:30

Session 310:30 - 11:30

Session 511:45 - 12:45

Session 714:15 - 15:15

IndustrySymposium

313:00 - 14:00

IndustrySymposium

417:30 - 19:00

Session 9Poster

Discussion #116:15 - 17:15

Session 208:30 - 09:30

Session 410:30 - 11:30

Session 611:45 - 12:45

Session 814:15 - 15:15

Session 10Poster

Discussion #216:15 - 17:15

Poster Viewing09:30 - 10:30

Breakfast Session07:15 - 08:15


Saturday, October 19, 2019

Castillo A 1-4 Castillo A 5-6 Exhibit Hall(Foyer)

07:00

07:30

08:00

08:30

09:00

09:30

10:00

10:30

11:00

11:30

12:00

12:30

13:00

13:30

14:00

14:30

15:00

15:30

16:00

16:30

17:00

17:30

18:00

18:30

19:00

19:30

20:00

20:30

21:00

21:30

Session 1108:30 - 09:15

Session 12 -Presidential Symposium

09:15 - 09:50

Special Session 12:00 - 12:30

Closing Ceremony16:00 - 16:30

IndustrySymposium

512:45 - 13:45

Session 1314:00 - 15:45

Session 1414:00 - 15:45

IndustrySymposium 613:00 - 13:30


Round TableDiscussions11:00 - 12:00


16

THU

RSD

AY,

OC

TOB

ER

17,

20

19


Time Event Presenter

08:15 – 15:30 IASLC Schools - Pre-Conferences (Ticketed Sessions)

09:00 – 15:15 Pre-Conference 1: IASLC School of Thoracic Oncology (Ticketed Session)Chairs: Christian Diego Rolfo, Feliciano Barrón and Narjust Duma

09:00 – 09:15 Welcome and Introduction: Program Overview Christian Diego Rolfo, Feliciano Barrón and Narjust Duma

09:15 – 09:30 Knowing IASLC: Why I Need to be Part? Clarissa Mathias

09:30 – 09:45 LATAM Activities Luis E. Raez

09:45 – 10:15 Reality of LATAM in Research Production: Frustration and Opportunities

Feliciano Barrón

10:15 – 10:40 Planning a Career in Lung Cancer – Academia Luis Paz Ares

10:40 – 11:00 Planning a Career in Lung Cancer – Clinical Yolanda Bautista

11:00 – 11:20 Conducting and Attracting Clinical Trials in Your Region: Mission Impossible?

Ticiana Leal

11:20 – 11:40 How to Become a Translational Physician Christian Diego Rolfo

11:40 – 12:00 A Grant: How to Get it? Edgardo S. Santos

12:00 – 12:30 Publish Your Research: Knowing the Process Christian Diego Rolfo

12:30 – 13:00 Lunch and Networking

13:00 – 14:30 Open Discussions Discussant

13:00 – 13:15 Mentorship-Mentee: Expectations and Realities Luis Paz Ares

13:15 – 13:30 Updating Your CV and Personal Statement Ticiana Leal

13:30 – 13:45 Time Management – Learning to Say No Heather Wakelee

13:45 – 14:00 How to Network Using Social Media Narjust Duma

14:00 – 14:15 My First Contract as Faculty: How to Survive Academic Centers Christian Diego Rolfo and Norma Pilnik

14:15 – 14:30 Learning from Our Experiences All Speakers

14:30 – 15:00 Building Your Multidisciplinary Team Feliciano Barrón

15:00 – 15:15 Wrap up and Adjourn Christian Diego Rolfo, Feliciano Barrón and Narjust Duma

Chairs: Oscar G. Arrieta | Saul Campos Fernando Aldaco | Jaime G De La Garza | Luis E. Raez | Christian Diego Rolfo | Edgardo S. Santos

08:15 – 15:30 Pre-Conference 2: IASLC School of Pathology (Ticketed Session)Chairs: Maria Arcila, Alejandro Aviles and Ignacio Wistuba

08:15 – 08:30 Welcome and Presentation of Program’s Objectives Maria Arcila, Alejandro Aviles and Ignacio Wistuba

08:30 – 08:50 Update of Classification - 2015 WHO Lung Cancer Classification Challenges and News About Classifications

Cristina Fernandez Ferradas

08:50 – 09:10 Update of Staging, Challenges for Pathologists Liliana Dalurzo

09:10 – 09:30 Major Pathological Response in Lung Cancer Neoadjuvant-Therapy

Ignacio Wistuba

09:30 – 09:45 Networking Break

09:45 – 11:00 Case Presentations: 3 or 4 CasesHandout of each case provided by a special faculty including information on clinical and laboratory data, and main questions to be addressed. Participants may be invited to share a case from their own laboratory.

Claudia Poleri, Alejandro Avilés, Rita Dotantes Heredia and Braulio Martínez Benítez

09:45 – 10:15 Discussion of the Cases in Small Groups

10:15 – 11:00 Review and Interpretation of the Clinical Cases by all Participants Moderated by the Provider Faculty

11:00 – 11:20 Multidisciplinary Approach to Tissue Acquisition and Management: How to Optimize Hospital Workflows to Maximize Tissue Use and Yield for Morphologic and Molecular Studies

Alejandro Aviles

11:20 – 12:00 Panel Discussion: CAP Guidelines for NGS Validation and Challenge for Latin America Laboratories Chair: Maria Arcila

Alejandro Aviles, Isabela W. Cunha and Federico Jauk

07:00 – 20:0007:00 – 21:3019:30 – 21:30

REGISTRATION DESK OPEN Location: Foyer Area (Mezzanine Floor)SPEAKER READY ROOM OPEN Location: Bosques (4th Floor)EXHIBIT HALL OPEN Location: Foyer Area (4th Floor)

LALCA2019.IASLC.ORG

17


17

THU

RSD

AY, O

CTO

BE

R 17, 20

19


12:00 – 12:15 Questions and Answers Alejandro Aviles and Maria Arcila

12:15 – 13:15 Lunch and Networking

13:15 – 14:45 Case Presentations: 3 or 4 CasesHandout of each case provided by a special faculty including information on clinical and laboratory data, and main questions to be addressed. Participants may be invited to share a case from their own laboratory.

Marileila Varella Garcia, Liliana Dalurzo, Cesar Lara Torres, Isabela W. Cunha and Federico Jauk

13:15 – 14:00 Discussion of the Cases in Small Groups Session Speakers

14:00 – 14:45 Review and Interpretation of the Clinical Cases by all ParticipantsModerated by the Provider Faculty

14:45 – 15:30 Round Table: Pathology and Molecular Pathology LA NetworkingChair: Ignacio WistubaAll participants - Moderated by IASLC Pathology Committee

15:30 Wrap up and Adjourn

09:00 – 15:30 Pre-Conference 3: IASLC School of Nursing (Ticketed Session)Chair: Enza Esposito Nguyen

09:00 – 09:05 Welcome and Introduction to the School of Nursing Enza Esposito Nguyen

09:05 – 09:20 The Role of the Nurse in Clinical Trials Lavinia Dobrea

09:20 – 09:40 Implementation and Management of a Lung Cancer Screening Program

Enza Esposito Nguyen

09:40 – 10:00 Lung Cancer Staging: What’s My Role? José Francisco Corona-Cruz

10:00 – 10:15 Panel Discussion Q&A Pre-Conference Speakers

10:15 – 10:30 Management of a Lobectomy Patient: Case Study José Francisco Corona-Cruz

10:30 – 10:45 Respiratory Rehab of the Postoperative Patient Marisol Arroyo Hernandez

10:45 – 11:00 Pain and Symptom Management in Early Stage Angela Acevedo



11:45 – 12:00 My Role in Stage IIIA Disease: Case Studies Jeronimo Rodríguez Cid

12:00 – 12:15 Chemotherapy, There is Still a Role Feliciano Barrón

12:15 – 12:30 Lung Cancer and Survivorship Lavinia Dobrea


12:45 – 13:00 Targeted Therapy and Side Effect Management: Case Studies Feliciano Barrón

13:00 – 13:15 Advances in Radiation Therapy Monika Blake

13:15 – 13:30 Nutritional Support of the Lung Cancer Patient Jenny Turcott



14:15 – 14:45 Immunotherapy and the Nurse’s Role in Management of Adverse Events: Case Studies

Enza Esposito Nguyen

14:45 – 15:00 Pain and Symptom Management in Advanced Lung Cancer Disease

Silvia Allende

15:00 – 15:15 Stigma Around Palliative Care Why This Exists and How to Manage

Camilla Zimmerman

15:15 – 15:30 Panel Discussion Q&A and Closure Pre-Conference Speakers


18



09:00 – 12:45 Pre-Conference 4: IASLC Advocacy Group Meeting (Ticketed Session)Chair: Patricia Mondragón

09:00 – 09:05 Welcome and Introduction to the Advocacy Program Patricia Mondragón

09:05 – 09:20 Latin America Panorama of Lung Cancer: Challenges and Opportunities

Adela Ayensa

09:20 – 09:40 Latin American Patients Panorama of Lung Cancer: Importance of Advocacy Programs

Ignacio Zerviño

09:40 – 10:00 Lung Cancer Advocacy Groups in Latin America: What’s Our Role? Nancy Ortiz Avilés


10:15 – 11:00 Palliative Care: Care to Improve the Quality of Life of the Patient. It is Not the Care of the End of LifeChair: Juanita Ruiz

10:15 – 10:30 Palliative Care to Improve the Quality of Life, Not Only for the End of It (Hospices)

Luz Elena Olaiz Cortina

10:30 – 10:45 Quantity or Quality of Life: Of Living More but Also Better; Management of Lung Cancer as a Chronic Disease - The Principle of Survival

Mariela Calzado Calderón



11:15 – 12:45 Patients Situation: How to Influence Public Policy to Improve the Current Situation of Lung Cancer Patients in Latin America Chair / Moderator: Cristina Duran and Diego Jimbo

11:15 – 11:30 Current Situation of Patients, Chronology of Improvements in Survival (Quality of Life) with Key Changes in Patient’s Panorama, Including a Look at a Historical and Current Histology

Eleazar Omar Macedo Pérez

11:30 – 11:45 Living with Lung Cancer - Is it Just Smokers’ Disease Stigma: How Does It Impact the Patient’s Life?

Tatiane Oyakawa

11:45 – 12:00 Access to Care Latin America: The Big Challenge Miryana Perez Vela

12:00 – 12:15 How to Improve Our Health System - Mexico Éctor Jaime Ramírez Barba

12:15 – 12:30 IASLC Patient Advocacy Kristin Richeimer and Kristin Ito

12:30 – 12:40 Q&A to the Different Speakers and Final Proposals

12:40 – 12:45 Final Comments and Closing Chair: Patricia Mondragón

13:00 – 15:00 Lung Cancer Living Room (Sign-up Required)Chairs: Oscar G. Arrieta, Clarissa Mathias and Luis E. Raez

THU

RSD

AY,

OC

TOB

ER

17,

20

19

16:00 – 21:30 IASLC Main Conference Program

16:00 – 17:00 Cancer Control Program and Tobacco ForumChairs: Elma Correa and Nise Yamaguchi

16:00 – 16:15 Implementing Interventions for Tobacco Control in LATAM: Research-based Policies

Juan Zinser Sierra

16:15 – 16:30 Importance of Smoking Cessation in the Treatment of Lung Cancer Patient

Carolyn Dresler

16:30 – 16:45 Molecular Surrogates of Tobacco Addiction and Immunological Interferences

Nise Yamaguchi

16:45 – 17:00 Panel Discussion Session Speakers

17:00 – 18:00 Simultaneous Sessions

17:00 – 18:00 Lung Cancer ScreeningChair: Renata Báez-Saldaña

17:00 – 17:15 Lung Cancer Screening in Key Populations: Overcoming Past Barriers Claudia Henschke

17:15 – 17:30 Lung Cancer Screening Results and the Economic Analysis David Yankelevitz

17:30 – 17:45 Where We Are in Lung Cancer Screening in Latin America? Challenges and Progress

Ricardo Santos


LALCA2019.IASLC.ORG

19


19


17:00 – 18:00 Release of Special Issue Session: Lung Cancer Epidemiology, Diagnosis and Treatment: Release of the Special Issue by “Salud Pública de México”Chair: Oscar G. Arrieta

17:00 – 17:05 Welcome Oscar G. Arrieta

17:05 – 17:15 The Need for Coverage: A Case for Lung Cancer in Mexico Sofia Charvel

17:15 – 17:30 A Patient’s Perspective Austrebertha Hernandez Cardona and Miriam Reyna Celaya

17:30 – 17:40 The Survival Benefit of New Generation Therapies Rafael Rosell

17:40 – 17:55 Access to Lung Cancer Therapy in Mexico Patricia Peralta and Wendy Briceño

17:55 – 18:00 Closing Eduardo Lazcano Ponce

18:00 – 18:45 IASLC-LATAM General Group Meeting Chairs: Luis E. Raez, Christian Diego Rolfo and Edgardo S. Santos

18:45 – 19:30 Opening CeremonyChair: Oscar G. Arrieta Co-Chairs: Saul Campos and Fernando Aldaco

18:45 – 18:55 Welcome and Introduction to LALCA 2019 Oscar G. Arrieta

18:55 – 19:20 IASLC Leadership WelcomeIASLC Immediate Past PresidentIASLC President IASLC President-ElectCEO

Giorgio Scagliotti Tetsuya MitsudomiHeather WakeleeDave Mesko

19:20 – 19:30 IASLC LALCA 2019 Awards Luis E. Raez andChristian Diego Rolfo

19:30 – 20:00 Welcome Reception

20:00 – 21:30 Industry Symposiums (#1)

FRID

AY, O

CTO

BE

R 18, 20

19



07:15 - 08:15 Breakfast Session: Women in Thoracic Oncology Chairs: Heather Wakelee, Clarissa Mathias, Narjust Duma, Raquel Garson Cwilich and Lucia Zatarain Barrón


08:30 – 09:30 Session 1: Diagnostic Imaging InnovationChairs: José Rogelio González Ramírez Benfield and Pedro García-Mantilla

08:30 – 08:45 Diagnosis in LATAM Region: Differences in Access to Technology

Marisol Arroyo Hernandez

08:45 – 09:00 EBUS and Navigation System to Yield a Diagnosis Francisco Tarrazzi

09:00 – 09:15 Interventional Radiology and RFA Jorge Guerrero Ixtlahuac

09:15 – 09:30 Panel Discussion Q&A Session Speakers

08:30 – 09:30 Session 2: Young Investigator’s Session and Research EnvisionChairs: Christian Caglevic and Narjust Duma

08:30 – 08:45 How to Write a Manuscript and a Research Grant Carlos Gil Ferreira

08:45 – 09:00 The Role of Medical School to Promote Basic and Clinical Research in LATAM

Norma Pilnik

09:00 – 09:15 Be an Author from LATAM: Challenges and Opportunities Lucia Zatarain Barrón


09:30 – 10:30 Networking Break and Poster Viewing

06:30 – 17:3007:00 – 19:0009:30 – 19:00



20

FRID

AY,

OC

TOB

ER

18,

20

19



10:30 - 11:30 Simultaneous Sessions

10:30 – 11:30 Session 3: 2019 American Society of Clinical Oncology (ASCO)/IASLC Symposia: Lung Cancer Pathology in the Era of Targeted TherapyChairs: Marileila Varella-Garcia and Liliana Dalurzo

10:30 – 10:45 Tissue Quality Control for Molecular Testing and Challenges in LATAM

Alejandro Aviles

10:45 –11:00 New Massive Parallel Sequencing Platforms (NGS) Versus Tailored Panels (ddPCR)

Ignacio Wistuba

11:00 – 11:15 Molecular Markers Available in LATAM Marileila Varella-Garcia


10:30 – 11:30 Session 4: Novel Diagnostic and Prognostic MarkersChairs: Edgardo S. Santos and Alberto Chiappori

10:30 – 10:45 Tumor Mutation Burden and Immunotherapy David R. Gandara

10:45 – 11:00 New Technologies for Liquid Biopsies and Looking for Cost Effective Options for LATAM (RT-PCR, cfRNA, Exosomes, ECVs and CTCs)

Luis E. Raez

11:00 – 11:15 Access to Biomarkers Analysis in Tissue and Blood for Our Patients in LATAM

Clarissa Baldotto



11:45 – 12:45 Session 5: Case Presentations and Review of New Developments in SurgeryChairs: José Francisco Corona-Cruz and Enrique Guzman

11:45 – 12:00 Multidisciplinary Management and Surgery for IIIA Disease Ricardo Terra

12:00 – 12:15 Management of Ground-glass Opacities (GGO) Ricardo Santos

12:15 – 12:30 Sublobar Resection for Stage I NSCLC Mark Block


11:45 – 12:45 Session 6: Adjuvant Therapy in the Molecular EraChairs: Clarissa Mathias and Gelenis Calzadilla Domingo

11:45 – 12:00 Role of Targeted Agents in the Adjuvant Setting Luis Alberto Mas Lopez

12:00 – 12:15 Immunotherapy in Lung Cancer Adjuvant Setting? Edgardo S. Santos

12:15 – 12:30 Which Adjuvant Therapy I Can Do in LATAM? Luis Corrales-Rodriguez


13:00 – 14:00 Industry Symposiums (#2 and #3)


14:15 – 15:15 Session 7: Radiotherapy InnovationsChairs: Gustavo Sarria and Monika Blake

14:15 – 14:30 SBRT for Oligometastatic Disease Beatriz Amendola

14:30 – 14:45 Role of SBRT in Early Stage NSCLC in LATAM Ana Botero

14:45 – 15:00 Optimal Radio Therapy for LA-NSCLC Puneeth Iyengar


14:15 – 15:15 Session 8: Case Presentations and Review of Combined Modality Therapy Chairs: Luis Ubillos and Rafael Rosell

14:15 – 14:30 Combining Radiation Therapy with Targeted Therapy in Oligometastatic Disease

Alberto Chiappori

14:30 – 14:45 Immunotherapy for Locally Advanced Disease Edgardo S. Santos

14:45 – 15:00 Is There a Role of Neoadjuvant Therapy in NSCLC? Ticiana Leal



LALCA2019.IASLC.ORG

21


21


16:15 – 17:15 Simultaneous Sessions (Poster Discussions)

16:15 – 17:15 Session 9: Poster Discussion # 1: Diagnosis, Early Stage and Locally AdvancedChairs: Saul Campos and Feliciano Barrón

16:15 – 16:20 PD1.01: Associations of Variability in Metabolic Parameters with Lung Cancer in the General Population

In Young Cho

16:20 – 16:25 PD1.02: Non-Small Cell Lung Cancer in the US Hispanic Population: A National Cancer Database Analysis

Goetz Kloecker

16:25 – 16:30 PD1.03: A Primer on Genetic Counseling on the Thoracic Oncology Unit. Family History of Lung Cancer in Two Independent Populations Tested for BRCA1 & amp;2 and EGFR

Guillermo Pacheco-Cuellar

16:30 – 16:40 Discussion by Discussant (10 min) Paul A. Bunn Jr.

16:40 – 16:45 PD1.04: Mid-term Outcomes of Uniportal Vats (U-VATS) for Early Lung Cancer

Kyoji Hirai

16:45 – 16:50 PD1.05: Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced Non-small-cell Lung Cancer (CLICAP-ABs)

Feliciano Barrón

16:50 – 16:55 PD1.06: Improving Survival of Oligometastatic NSCLC with Stereotactic Body Radiation Therapy

Luis E. Raez

16:55 – 17:05 Discussion by Discussant (10 min) Luis Paz Ares

17:05 – 17:15 Conclusion and Panel Discussion Session Poster Speakers

16:15 – 17:15 Session 10: Poster Discussion # 2: Metastatic DiseaseChairs: Giorgio Scagliotti and Luis Corrales-Rodriguez

16:15 – 16:20 PD2.01: PD-L1 and Other Potential Predictive Biomarkers Measured in Plasma by RT-PCR in cfRNA and cfDNA to Monitor Clinical Responses in Metastatic Lung Cancer Patients

Luis E. Raez

16:20 – 16:25 PD2.02: Pembrolizumab plus Pemetrexed-Platinum for Patients with Metastatic Nonsquamous NSCLC and Liver or Brain Metastases: Results from KEYNOTE-189

Delvys Rodríguez-Abreu

16:25 – 16:30 PD2.03: Exploration of Factors Relating to Immune Response in Patients Treated with Immune Checkpoint Inhibitors for Non-small Cell Lung Cancer (NSCLC)

Claudio Martín

16:30 – 16:40 Discussion by Discussant (10 min) David R. Gandara

16:40 – 16:45 PD2.04: Long Term Efficacy and Safety of Ensartinib in Pre-treated Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung Cancer (NSCLC) Patients (eXalt2)

Ticiana Leal

16:45 – 16:50 PD2.05: Overall Survival in Pts with EGFRm+ NSCLC Receiving Sequential Afatinib and Osimertinib: Updated Analysis of the GioTag Study

Jose Waingarten

16:50 – 16:55 PD2.06: EGFR Inhibitors + Bevacizumab Demonstrated Superior Efficacy Compared with EGFR Inhibitors Alone as First-line Treatment in Advanced NSCLC Patients with EGFR Mutations and BIM Deletion Polymorphisms

Andrés F. Cardona

16:55 – 17:05 Discussion by Discussant (10 min) Heather Wakelee

17:05 – 17:15 Conclusion and Panel Discussion Session Poster Speakers

17:30 – 19:00 Industry Symposiums (#4)

FRID

AY, O

CTO

BE

R 18, 20

19


22

SATU

RD

AY,

OC

TOB

ER

19,

20

19

Saturday, October 19, 2019


08:30 – 09:15 Session 11: New Developments in Targeted Therapy for Other Thoracic Malignancies Chairs: Ticiana Leal and Rogelio Trejo

08:30 – 08:45 Is There a Targeted Therapy for SCLC? Gelenis Calzadilla Domingo

08:45 – 09:00 Mesothelioma: Challenges in Diagnosis and Therapeutic Outlook, What We Can Do in LATAM?

Diego Luca Kaen

09:00 – 09:15 Novel Therapies for Malignant Thymoma and Mesothelioma Jorge Gomez

09:15 – 09:50 Session 12: Presidential SymposiumChairs: Oscar G. Arrieta and Tetsuya Mitsudomi

09:15 – 09:20 Welcome and Introductions Oscar G. Arrieta and Tetsuya Mitsudomi

09:20 – 09:25 O.01: Challenges of Interpreting NGS Liquid Biopsy (LB) Results in Advanced NSCLC: Are ESCAT and OncoKB Scales Reliable?

Christian Diego Rolfo

09:25 – 09:30 O.02: Long-term Survival Outcomes with Nivolumab (NIVO) in Pts with Previously Treated Advanced Non-small Cell Lung Cancer (NSCLC): Impact of Early Disease Control and Response

Yolanda Bautista

09:30 – 09:35 O.03: KEYNOTE-189: OS Update and Progression After the Next Line of Therapy (PFS2) with Pembrolizumab + Chemotherapy for Metastatic Nonsquamous NSCLC

Delvys Rodríguez-Abreu

09:35 – 09:40 O.04: Results from the IASLC Global Survey on Molecular Testing in Lung Cancer

Marileila Varella Garcia

09:40 – 09:50 Discussion by Discussant (10 min) David R. Gandara


11:00 – 12:00 Round Table Discussions (16 tables)Chairs: Eduardo Richardet and Feliciano Barrón

Round Table 1: Early Stage Lung Cancer: Adjuvant Treatment Coordinator (Facilitator): Norma Pilnik and Edgardo S. Santos

Round Table 2: Novel Approaches in Surgery. Robotic Surgery, Vats, Navigation System Coordinator (Facilitator): Francisco Tarrazzi, Ricardo Terra and Ricardo Santos

Round Table 3: Treatment of Wild Type Lung Cancer Tumors. First and Second Line Coordinator (Facilitator): Paul A. Bunn, Jr., Eduardo Richardet and Carlos Carracedo

Round Table 4: Therapy of Tumors Carrying EGFR MutationsCoordinator (Facilitator): Giorgio Scagliotti, Rafael Rosell and Luis Corrales-Rodriguez

Round Table 5: ALK Positive TumorsCoordinator (Facilitator): Luis Paz Ares, Ticiana Leal and Christian Caglevic

Round Table 6: How to Study Molecular Biology and Tumor Markers Coordinator (Facilitator): Fred R. Hirsch, Ignacio Wistuba and Liliana Dalurzo

Round Table 7: New Molecules and Therapies for Lung Cancer Coordinator (Facilitator): David R. Gandara, Claudio Martin and Oscar G. Arrieta

Round Table 8: Oligometastatic Lung Cancer Coordinator (Facilitator): Delvys Rodriguez-Abreu, Beatriz Amendola and William William

Round Table 9: Diagnosis and Staging in Lung Cancer Coordinator (Facilitator): Mark Block and Luis Ubillos

Round Table 10: Locally Advanced Lung Cancer Coordinator (Facilitator): Ana Botero, Luis Alberto Mas Lopez, Nise Yamaguchi and Puneeth Iyengar

Round Table 11: Immunotherapy in Non-Small Lung Cancer Coordinator (Facilitator): Clarissa Mathias, Luis E. Raez and Ignacio Gil-Bazo

Round Table 12: Liquid Biopsy Coordinator (Facilitator): Christian Diego Rolfo, Alejandro Aviles and Marileila Varella-Garcia

Round Table 13: Uncommon Oncology Drivers: ROS1, BRAF, NTRK, MMR, RETCoordinator (Facilitator): Jorge Gomez and Alberto Chiappori

Round Table 14: Small Cell Lung Cancer Coordinator (Facilitator): Narjust Duma, Feliciano Barrón and Gelenis Calzadilla Domingo

Round Table 15: Pain Management and Palliative CareCoordinator (Facilitator): Camilla Zimmerman, Silvia Allende and Saul Campos

Round Table 16: Management of Patients Who Has Failed Targeted Therapy or Immunotherapy - What We Do Next? What Is Coming?Coordinator (Facilitator): Heather Wakelee and Diego Lucas Kaen

07:30 – 16:0007:30 – 16:3009:30 – 16:30


LALCA2019.IASLC.ORG

23


23

SATU

RD

AY, O

CTO

BE

R 19, 20

19


12:00 – 12:30 Special Session: How to Publish a Manuscript in the IASLC Journal of Thoracic Oncology: Strengths and Weakness in LATAMModerator: Luis E. RaezPanel Discussion: Alex Adjei, Mary Todd and Carlos Gil Ferreira

12:45 – 13:45 Industry Symposiums (#5 and #6)

14:00 - 15:45 Simultaneous Sessions (10 min Presentations)

14:00 – 15:45 Session 13: Targeted TherapyChairs: Oscar G. Arrieta and Alejandro Aviles

14:00 – 14:10 Tyrosine Kinase Inhibitors for EGFR Giorgio Scagliotti

14:10 – 14:20 ALK Genomic Aberrations Fred R. Hirsch

14:20 – 14:30 cMET/BRAF/RET/PARP Inhibitors Paul A. Bunn Jr.

14:30 – 14:40 ROS-1 Translocations Christian Diego Rolfo

14:40 – 14:50 NTRK Fusion Proteins Luis E. Raez

14:50 – 15:00 New Insights of EGFR Inhibition: How to Overcome Resistance and New Agents

Rafael Rosell

15:00 – 15:10 EGFR/ALK TKIs with Central Nervous System Penetration Ignacio Gil-Bazo

15:10 – 15:20 Algorithm for Targeted Therapies in LATAM: A Reality Conditioned by the Access Policy

Luis Corrales-Rodriguez


14:00 – 15:45 Session 14: ImmunotherapyChairs: Eduardo Richardet and Norma Pilnik

14:00 – 14:10 Front Line Immunotherapy for NSCLC What is New Luis Paz Ares

14:10 – 14:20 Checkpoint Inhibitor Combinations Among Themselves and with Chemotherapy

Heather Wakelee

14:20 – 14:30 Immunotherapy Resistance and New Agents Delvys Rodrigues -Abreu

14:30 – 14:40 Molecular Markers for Immunotherapy Christian Diego Rolfo

14:40 – 14:50 Combining Immunotherapy with Targeted Therapy? Jorge Alatorre Alexander

14:50 – 15:00 Small Cell Lung Cancer Immunotherapy William William

15:00 – 15:10 Challenges with Immune Checkpoint Inhibitors in Clinical Practice

Alex Adjei

15:10 – 15:20 Clinical Cases of Immunotherapy and Oligometastatic Disease Claudio Martin


16:00 – 16:30 Closing CeremonyChair: Oscar G. Arrieta Award Presentations – Tetsuya MitsudomiIntroducing LALCA 2021 - Luis Ubillos and Mario Varangot


24

PO

STE

R S

ESS

ION

1 |

FRID

AY,

OC

TOB

ER

18,

20

19

Poster Session 1 | Friday, October 18, 2019

PREVENTION, EARLY DETECTION, EPIDEMIOLOGY AND TOBACCO CONTROL

P1.01 EGFR Mutations in Lung Cancer in Northern Mexic Population Juan Pablo Flores Gutiérrez, Mexico P1.02 ALK Gene Rearrangement in Patients with Lung Cancer in Northern Mexican Population Juan Pablo Flores Gutiérrez, Mexico

P1.03 Case Series of Double Mutations in Patients with Lung Adenocarcinoma Juan Pablo Flores Gutiérrez, Mexico

P1.04 Prevalence, Pattern and Factors Associated with Dual Tobacco Use in a Rural Community in South Eastern Nigeria Uzochukwu Ofonakara, Nigeria P1.05 Lung Cancer Patients – Major Causes of Hospitalization and Mortality Catarina Custódio, Portugal P1.06 Determination of Exposure to Tobacco Smoke and the Percentage of Global DNA Methylation in Smokers and Patients with Lung Cancer Alejandra Guadalupe Alcázar-Ramos, Mexico P1.07 Habits in Tobacco Consumption of a Population of Queretaro Karla Liliana García-Mejía, Mexico

P1.08 A Retrospective Study of 230 Cases of Lung Disease - Talk about the Relationship Between Heavy Physical Labor and Lung Cancer Yu Zhang, China

P1.08-A Sherlock Lung Tracing Lung Cancer Mutational Processes in Never-smokers Laura Mendoza, United States of America

SCLC, MESOTHELIOMA, THYMOMA

P1.09 Heterogeneous versus Homogeneous Radiation Dose Calculations of Twice Daily Fractionation in Small Cell Lung Carcinoma Jeffrey Bogart, United States of America P1.10 Survival of Thymoma Is Extensive in Latin- American Patients: Results from over 10 Years of Experience (CLICaP-LATimus) Feliciano Barrón, Mexico P1.11 Multicenter Study of Histological Types Incidence and Pathological Features of Malignant Pleural Mesothelioma (MPM) in Argentina Claudia Poleri, Argentina P1.12 Real World Characterization and Treatment Patterns of Patients with Thymic Carcinoma: Lessons from a Latin American Collaborative Study (CLICaP-LATimus) Luis Mas, Peru P1.13 Advanced Small Cells Lung Cancer: 5 Year Experience at the National Oncology Institute of Panama, 2014-2018 Taysser Sowley, Panama

P1.14 Morbidity, Mortality and Oncologic Outcomes in Bronchoplastic Procedures Performed in a Mexican Public Reference Hospital Benjamin Zavala Retes, Mexico

P1.16 Awake Thoracoscopic Lung Cancer Biopsy Emmanuel Peña Gomez Portugal, Mexico

P1.16-A Surgical Therapy for Malignant Pleural Mesothelioma in Mexican Population Maria Esther Marmolejo Torres, Mexico

BIOLOGY AND PATHOGENESIS P1.17 How to Visualize Exosomes in NSCLC: “The New Guest Star in the Liquid Biopsy Movie” Christian Diego Rolfo, United States of America P1.18 Update of the Analysis of the Status of Lymphocyte Infiltration in Patients with NSCLC Eduardo Richardet, Argentina P1.19 Molecular Characterization of Lung Cancer in Young Patients. A Single-center Study from Argentina Liliana Dalurzo, Argentina P1.20 S-allyl Cysteine Induces Cytotoxic Effects on Human NSCLC Cell Lines Mario Orozco-Morales, Mexico

BRONCHOSCOPY P1.21 Cryotherapy in the Treatment of Endobronchial Carcinoid, Is It a Valid Alternative Treatment to Surgery? Periklis Perikleous, United Kingdom P1.22 Endobronchial Ultrasound and Transbronchial Needle Aspiration EBUS-TBNA: In a University Hospital in Latin America Liliana Fernandez-Trujillo, Colombia P1.23 EBUS and Needle Aspiration in Diagnosis and Molecular Classification of Breast Cancer Progression Metastatic to Mediastinum Liliana Fernandez-Trujillo, Colombia

P1.24 Endobronchial Ultrasound plus Fine Needle Aspiration (EBUS-TBNA) in Lesions Simulating Pulmonary Neoplasm: Pulmonary Myospherulosis Liliana Fernandez-Trujillo, Colombia

P1.25 Rare Intimal Aortic Angiosarcoma Diagnosed via Endobronchial Ultrasound guided Transbronchial Fine Needle Aspiration (EBUS-TBNA): A Case Report Liliana Fernandez-Trujillo, Colombia

NURSING & ALLIED HEALTH P1.26 Pharmaceutical Follow-up Program for Patients with Oral Drug Treatment in Non-small Cell Lung Cancer in a Heterogeneous Health Care System Gisele Moreira, Brazil

Exhibit HallPresenting Author Standby Time: 09:30 – 10:30, 15:15 – 16:15

LALCA2019.IASLC.ORG

25


25

PO

STER

SESSIO

N 2 | SA

TUR

DA

Y, OC

TOB

ER

19, 2019

Poster Session 2 | Saturday, October 19, 2019

EARLY STAGE NSCLC (STAGE I - III) P2.01 Prognosis of Patients with Stage I Non-Small Cell Lung Cancer Claudio J. Flores, Peru

ADVANCED NSCLC

P2.02 Second-line Afatinib vs Erlotinib for Advanced Lung Squamous Cell Carcinoma: Final Analysis of the Phase 3 LUX-Lung 8 Trial Jose Waingarten, Mexico P2.03 Normalization of Carcinoembryonic Antigen Levels Are Associated with a Survival Improvement in Advanced Non-small Cell Lung Cancer Patients Roberto Sánchez Reyes, Mexico P2.04 NGS-Molecular Characterization of Lung Adenocarcinomas from Hispanic Patients: Level of Evidence for Therapeutic Actionability Oscar Arrieta, Mexico P2.05 Real World Data on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Use in Advanced Non-small Cell Lung Cancer from a Latin American Cohort Marco Galvez-Nino, Peru P2.06 Lung Cancer Driver Mutations and PD-L1 Expression in US Latino Patients with Advanced Lung Cancer Diana Saravia, United States of America P2.07 Prevalence of Hypovitaminosis D in Patients with Advanced Adenocarcinoma of Smokers and Non-smokers Imanuely Borchardt Gonçalves, Brazil P2.08 Osimertinib for Metastatic, EGFR Mutated Non- small Cell Lung Cancer. Real World Evidence at National Oncology Institute, Panama Franklin Castillero, Panama P2.09 Access and Outcomes of TKI EGFR in Lung Cancer Treatment from Uruguayan Population Mauricio Cuello, Rodriguez Palleiro, Uruguay P2.10 Mutational EGFR Profile in Mexican Patients with Pulmonary Adenocarcinoma Measured by New Generation Sequencing (NGS) Carla Paola Sánchez Ríos, Mexico P2.11 Three Years of Experience with ALK-positive Patients Joana Batista Correia, Portugal P2.12 Clinical and Tomographic Description of Mexican Patients with Lung Cancer with ALK Positive Carla Paola Sánchez Ríos, Mexico P2.13 Frequency of Uncommon EGFR Mutations in Costa Rica Alejandra Mendez, Costa Rica P2.14 Response Profile of Non-small Cells Lung Cancer with ALK Positive Treated with Alectinib Carla Paola Sánchez Ríos, Mexico P2.15 Progression under Osimertinib, What Now? Catarina Custódio, Portugal

P2.15-A Panorama Retro: Real World Evaluation of Molecular Testing and Treatment Patterns for EGFR Mutations in Patients with Advanced or Metastatic NSCLC (D133FR00143) Claudio Martín, Argentina P2.15-B Update of Mutation Status and PDL1 Expression in Lung Cancer. A Multicenter Local Study Norma Pilnik, Argentina P2.15-C Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non- small Cell Lung Cancer Haby Henary, United States of America

PATHOLOGY

P2.16 PD-L1 Expression in a Population with Non-Small Cell Lung Cancer in a Reference Healthcare Center in Latin-America Liliana Fernandez-Trujillo, Colombia P2.17 Intersegmental Plane Identification with Single Lung Ventilation in PSN Resection Emmanuel Peña Gomez Portugal, Mexico P2.18 Sternal Cavernous Hemangioma and Anterior Thoracic Wall Reconstruction: Case Report Liliana Fernandez-Trujillo, Colombia P2.19 Pulmonary Metastasis in a Patient with Multiple Primary Adenocarcinomas: A Case Report Liliana Fernandez-Trujillo, Colombia

IMMUNOTHERAPY

P2.21 Clinical Responses and Survival in Hispanic Patients vs Non-Hispanic White Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy Diana Saravia, United States of America P2.22 Immunotherapy-related Thrombosis: Considerations and Associated Factors in Non-small Cell Lung Cancer (NSCLC) Patients Luis Corrales-Rodriguez, Costa Rica P2.23 Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy Oscar Arrieta, Mexico P2.24 Lung Immune Prognostic Index in Patients with Non-small Cell Lung Cancer Treated with Either Chemo or Immunotherapy Feliciano Barrón, Mexico P2.25 Immunotherapy at Any Line of Treatment Improves Survival in Hispanic Patients with Advanced Metastatic Non-small Cell Lung Cancer (NSCLC) Compared with Chemotherapy (Quijote-CLICaP) Andrés F. Cardona, Columbia P2.26 Budget Impact Analysis of Immunotherapy as Second-line Treatment of NSCLC at Mexico’s National Institute of Cancer Laura Alejandra Ramírez Tirado, Mexico

Exhibit HallPresenting Author Standby Time: 10:00 – 11:00


26

LALC

A 20

19 TR

AV

EL A

WA

RD

S

Congratulations to the following LALCA 2019 Travel Award Winners!

Award Winners will be presented with their awards during the Closing Ceremony on Saturday, October 19 from 16:00 – 16:30.

Alejandra Guadalupe Alcázar-Ramos

P1.06 - Determination of Exposure to Tobacco Smoke and the Percentage of Global DNA Methylation in Smokers and Patients with Lung Cancer

Poster Session 1, Friday, October 18

Franklin Castillero

P2.08 - Osimertinib for Metastatic, EGFR Mutated Non-small Cell Lung Cancer. Real World Evidence at National Oncology Institute, Panama

Poster Session 2, Saturday, October 19

Marco Galvez-Nino

P2.05 - Real World Data on Epidermal Growth Factor Recep-tor Tyrosine Kinase Inhibitors Use in Advanced Non-small Cell Lung Cancer from a Latin American Cohort


Karla Liliana García-Mejía

P1.07 - Habits in Tobacco Consumption of a Population of Queretaro


Imanuely Borchardt Gonçalves

P2.07 - Prevalence of Hypovitaminosis D in Patients with Ad-vanced Adenocarcinoma of Smokers and Non-smokers


Gisele Moreira

P1.26 - Pharmaceutical Follow-up Program for Patients with Oral Drug Treatment in Non-small Cell Lung Cancer in a Het-erogeneous Health Care System


Carla Paola Sánchez Ríos

P2.14 - Response Profile of Non-small Cells Lung Cancer with ALK Positive Treated with Alectinib


LALCA 2019 Travel AwardsLA

LCA

20

19 T

RA

VE

L A

WA

RD

S

LALCA2019.IASLC.ORG

27


27

ME

XIC

O C

ITY IN

FOR

MA

TION

Time ZoneMexico City is in the Central Standard Time Zone. The time difference is:

UTC/GMT -5 hoursCentral Europe (ie London) -6 hoursEST (ie New York) -1 hourPST (ie San Francisco) 2 hours

Electric PowerElectrical plugs are the same as in the USA.

Standard Voltage: 110-127 V (Standard voltage at Hotel is 110 V)Standard Frequency: 60 HzPower Sockets: type A / B

BanksMany of world’s largest banks are represented in Mexico. Most bank branches are open Mondays through Fridays from 9:00 – 16:00. Most banks accept major credit cards.

CurrencyMexico’s currency is the Mexican Pesos (sign: $). Mexican bank notes are printed in denominations of 20, 50, 100, 200, 500 and 1,000 pesos. Coins come in denominations of 1, 2, 5, 10 and 20 pesos, and 20 and 50 centavos (100 centavos = 1 peso).

Airport TaxiTaxi services are located at the international and domestic entrances at Terminals 1 and 2. In both cases, taxi tickets are sold at the modules located near the arrival gates and in the walkway area. Rates are posted in a visible place and are authorized by the Secretaría de Comunicaciones y Transportes (SCT). For your safety, we recommend you only use the taxi services authorized by this airport.

Uber / Taxi in the City Uber is highly used in Mexico City as a reliable ride, from low-cost to premium. Payment is done either in cash, credit card or Uber Cash balance.

Sign up from the below official website of Uber for your ride within downtown Mexico City.

The cost of an Uber trip depends on the type of ride you request, the estimated distance, duration of the trip, tolls and current demand for rides. Use of a price estimator located in the below website is recommended before taking the ride. https://www.uber.com/global/en/airports/mex/

More instructions on how Uber works is found here: https://www.uber.com/ca/en/ride/how-it-works/

Tipping Tipping in Mexico is a common practice across the country. It is good etiquette and supplements the modest wages of employees. If you are happy with your service, it is standard to leave a 10-15 % gratuity. If you are tipping using US dollars, only use bills, since coins are not exchangeable to pesos.

LanguageThe main and official language in Mexico is Spanish. Hotel personnel do speak English.

Mexico City Information


28

TOU

RS

LALCA 2019 has partnered with DMS Mexico, a local tour specialist to provide delegates with the opportunities to explore Mexico City and surroundings. For details and to book a tour on-site, please visit the Tour Information Desk located next to the Registration Desk. Please note that a minimum of 10 participants are needed for each tour.

Tania RuizBusiness Relationship ManagerDestination Management Services de Mexico

AddressRio Duero 46, Mexico CityPhone: +52 55 5533 6154

Tours

Downtown Mexico City Tour Half dayPrice per person: 45 USD

Available on October 17, 18, 19 and 20

Museums of Mexico City Half dayPrice per person: 62 USD

Available on October 17, 18, 19 and 20

Frida Kahlo Tour Half dayPrice per person: 62 USD

Available on October 19 and 20

City of Gods Tour Full day (buffet lunch included)Price per person: 98 USD

Available on October 19 and 20

For more information and full descriptions of the tours, please visit the Conference website.

Photo by FMPT CDMX

Photo by FMPT CDMX

Photo by Ricardo Gomez Garrido and FMPT CDMX

Photo by DMS Mexico

LALCA2019.IASLC.ORG

29


29

AU

THO

R IN

DE

X

Author Index

AAbbas Jad ...................................................................................................P2.13Abubakar Mustapha .......................................................................... P1.08-AAcevedo, Angela Maria .............................................................................. I.3Acosta Haab Gabriela ...............................................................................P1.11Acosta Luciana ...........................................................................................P1.18Agrawal Shruti ...........................................................................................O.02Aguilar Alfredo .........................................................................................P2.01Aguirre Marisol ......................................................................................... P2.16Alatorre Alexander Jorge ........................................................P2.10, P2.14Alcázar-Ramos Alejandra Guadalupe ................................P1.06, P1.07Alessandro Riccardo ................................................................................P1.17Alexander Meza José ............................................................................P2.04Alexandrov Ludmil ............................................................................. P1.08-AAmendola, Beatriz ......................................................................................I.15Amorin Edgar ..........................................................................................P2.05Anikin Vladimir .......................................................................................... P1.21Antonia Scoot J ........................................................................................O.02Antonia Scott ............................................................................................ P2.21Arauchan Sandra .................................................................................P2.15-AArchila Pilar .......................................................PD1.05, P1.10, P1.12, P2.22, ........................................................................ P2.23, P2.25, PD2.03, PD2.06Ardizzoni Andrea ................................................................................... P2.02Arora Arshia .............................................................................................P2.06Arrieta Oscar .............I.9-1, P1.08-A, P1.10, P1.12, P1.20, P2.03, P2.04,................................P2.22, P2.23, P2.24, P2.25, P2.26, PD2.03, PD2.06Asadi Nizar ................................................................................................. P1.21Ávila Jenny .......................PD1.05, P1.10, P1.12, P2.22, PD2.03, PD2.06

BBáez Saldaña Renata ..........................................................................P1.16-ABals Sara .......................................................................................................P1.17Barajas Olga ..........................................................................................P2.15-ABarata Fernando ........................................................................................P2.11Barboza Quintana Oralia ..............................................P1.01, P1.02, P1.03Barrios-Bernal Pedro .............................................................................P1.20Barrón Feliciano................................PD1.05, P1.10, P1.12, P2.03, P2.22, .............................................P2.23, P2.24, P2.25, P2.26, PD2.03, PD2.06Bas Carlos ....................................................................................P2.23, P2.25Basher Fahmin ........................................................................................P2.06Bautista Yolanda ...................................................................I.1-1, I.1-2, O.02Beddow Emma .......................................................................................... P1.21Bender Shaun .......................................................................................... P2.02Bengio V .................................................................................................P2.15-BBerrios Mejia Juan Alberto ...............................................................P1.16-ABertadillo-Jilote Alma Delia ................................................................P1.06Berutti Susana ......................................................................................P2.15-ABhandari Shruti .....................................................................................PD1.02Bischoff Helge G. .....................................................................O.03, PD2.02Blake, Monika ................................................................................................. I.4Blanco Carolina .......................................................................................P2.04Block, Mark ....................................................................................................I.14Blumenschein George R. ..................................................................PD2.04Bogart Jeffrey ......................................................................................... P1.09Bolaños Morales Francina ..................................................................... P1.16Bonilla Carlos ........................................................................................P2.15-ABotero Ana .............................................................................................PD1.06Boyer Michael ...........................................................................O.03, PD2.02Brahmer Julie .............................................................................................O.02Bravo-Garzón Maria A. ............................................................P2.23, P2.25Bravo Melissa .................................................................................. P1.10, P1.12Buenaventura Daisy C. .......................................................................... P1.25Bunn Jr., Paul A. ...........................................................................................I.18Burgio Marco A .........................................................................................O.02Butts Charles .............................................................................................O.02

CCabada, German ................................................................................ I1.-1, I.1-2Cabero Octavio .......................................................................................P2.05Cabrera Luis .............................................................................................P2.03Calderon Camilo A.................................................................................. P2.19Calha Jaime ................................................................................................P2.15Calvinho Paulo ..........................................................................................P2.15

Campos-Gomez Karen .......................................................................PD1.03Campos-Gomez Saul ..........................................................................PD1.03Cañas Yuliana............................................................................................ P1.23Canigiani M ............................................................................................P2.15-BCardellino Anna ...................................................................................PD2.02Cardona Andrés F. ............................ PD1.05, P1.10, P1.12, P2.03, P2.22, ..........................................................P2.23, P2.25, P2.26, PD2.03, PD2.06Carranza Hernán .................................PD1.05, P1.10, P1.12, P2.22, P2.23, ..................................................................................... P2.25, PD2.03, PD2.06Carranza Omar ...........................................................................P2.23, P2.25Carrillo Vidales Javier .............................................................................P2.17Castellon Ignacio ..................................................................................PD1.06Castillero Franklin ..................................................................................P2.08Castillo Miguel .......................................................................................PD1.06Castillo Omar ................................................................................P1.13, P2.08Castro Andres ........................................................................................... P1.22Castro-Bernardini, Socorro ...................................................................... I.10Chávez Millan Marisa Florentina ....................................................... P2.26Cheng Susanna Yee-Shan ....................................................O.03, PD2.02Chen Jingjing ..............................................................................................O.01Chiappori Alberto ...............................................................................PD2.04Chirinos Luis ..............................................................................................P2.01Cho In Young .........................................................................................PD1.01Chow Laura Q M .......................................................................................O.02Christiani David ................................................................................... P1.08-AClaes Nathalie .............................................................................................P1.17Clingan Philip ........................................................................................PD2.02Cobo Manuel ............................................................................................ P2.02Colín-González Ana Laura ...................................................................P1.20Corassa Marcelo............................................................................. P1.10, P1.12Cordeiro De Lima Vladmir Cláudio ....................... PD1.05, P1.10, P1.12, ......................................................................................P2.22, PD2.03, PD2.06Corrales-Rodriguez Luis .................. PD1.05, P1.10, P1.12, P2.03, P2.13, .......................................................... P2.22, P2.23, P2.25, PD2.03, PD2.06Correia Joana Batista .............................................................................P2.11Cotta Jared ...............................................................................................P2.06Cress Doug ................................................................................................ P2.21Crino Lucio .................................................................................................O.02Crismatt Alejandro .....................................................................P1.13, P2.08Cseh Agnieszka .......................................................................................P2.02Cuello Mauricio ......................................................................P2.09, P2.15-ACufer Tanja .............................................................................................PD2.05Cundom Juan .......................................................................................P2.15-ACustódio Catarina ......................................................................P1.05, P2.15

DDalurzo Liliana ..........................................................O.04, I.1-3, P1.11, P1.19Danenberg Kathleen ...........................................................................PD2.01Danenberg Peter ..................................................................................PD2.01De Angelis Flávia .................................................................................PD2.02De La Garza Salazar Jaime ................................................................. P2.26Delgado Lucia .........................................................................................P2.09Demellis Gabriela .......................................................................................P1.11De Miguel-Pérez Diego ...........................................................................P1.17Denlinger Crystal S .............................................................................P2.15-CDesai Jayesh .........................................................................................P2.15-CDiaz De Arce Heidy ................................................................................. P1.19Domine Manuel ....................................................................................PD2.02Domingo Gelenis ..................................................................................PD2.01Dresler Carolyn ............................................................................................. I.9Drilon Alexander .......................................................................................O.02Durm Greg .............................................................................................P2.15-C

EEkesi Onyinye Emmanuella .................................................................P1.04Enriquez Daniel ........................................................................................P2.01Esteban Emilio..........................................................................O.03, PD2.02

FFakih Marwan G ...................................................................................P2.15-CFalchook Aaron .....................................................................................PD1.06Falchook Gerald S ...............................................................................P2.15-C

PRESENTATIONS HIGHLIGHTED IN BOLD = PRESENTING AUTHOR FOR THIS ABSTRACT


30

AU

THO

R IN

DE

X

Falcoff Nora ..................................................................................................P1.11Fanfan Dino ..............................................................................................P2.06Felip Enriqueta ............................................... O.03, O.04, P2.02, PD2.02Felizardo Margarida ...................................................................P1.05, P2.15Fernandez-Trujillo Liliana .............................P1.22, P1.23, P1.24, P1.25, .............................................................................................. P2.16, P2.18, P2.19Ferreira Amanda ..................................................................................... P2.07Ferreira Carlos Gil ......................................................................P1.26, P2.07Ferreira Gimena .........................................................................................P1.18Figueiredo Ana ..........................................................................................P2.11Figueroa-Corona María Del Pilar .......................................... P1.06, P1.07Finch Jonathan ......................................................................................... P1.21Flores Claudio J. ......................................................................................P2.01Flores Gutiérrez Juan Pablo ......................................P1.01, P1.02, P1.03Flores Soto Maria Del Rosario ............................................................ P2.10Fraga Gisele ............................................................................................. P2.07Franco Cortes Claudia Alejandra ....................................................... P1.19Freitas Helano .................PD1.05, P1.10, P1.12, P2.22, PD2.03, PD2.06Furtado Sofia ................................................................................P1.05, P2.15

GGadgeel Shirish ........................................................................O.03, PD2.02Gajra Ajeet .................................................................................................P1.09Galvez-Nino Marco ................................................................................P2.05Garassino Marina C. .................................................... O.02, O.03, PD2.02Garcia Bazan Eric Marco ....................................................................... P1.14Garcia-Closas Montse ....................................................................... P1.08-AGarcia Cocco Virginia ........................................................................P2.15-AGarcía-Gutiérrez David Gustavo ........................................................P1.06Garcia Juan E. ........................................................................................... P1.25García-Mantilla Pedro ................................................................................I.10Garcia Marileila Varella .......................................................................... O.04García-Mejía Karla Liliana ........................................................P1.06, P1.07Garon Edward B. .....................................................................O.03, PD2.02Garza Guajardo Raquel .................................................P1.01, P1.02, P1.03Georgoulias Vassilis ............................................................................... P2.02Gerson Raquel .........................................................................................P2.04Gettinger Scott .........................................................................................O.02Getz Gaddy .......................................................................................... P1.08-AGil-Bazo Ignacio ........................................................................................ I.20Gittens Allison ............................................................................................O.01Göker Erdem ............................................................................................ P2.02Gómez Alvaro .......................................................................................P2.15-AGonçalves Imanuely Borchardt ............................................ P1.26, P2.07Goncalves Susana ...............................................................................P2.15-AGordenin Dmitry ................................................................................. P1.08-AGoss Glenwood D. .................................................................................. P2.02Govindan Ramaswamy .....................................................................P2.15-CGray Jhanelle E. ...................................................................................PD2.02Grossi Francesco .................................................................................PD2.02Gucalp Rasim ........................................................................................PD2.05Guerrero Ixtlahuac Jorge .........................................................................I.12Guillen Maria ............................................................................................P2.05Guman Gabriela ..........................................................................................P1.11Gunasekaran Muthukumar .....................................................................P1.17

HHalmos Balazs ......................................................................................PD2.05Han Kyungdo ..........................................................................................PD1.01Hao Desiree ...........................................................................................PD2.05Harrow Kim ............................................................................................PD2.04Henary Haby ........................................................................................ P2.15-CHernández Marisol Arroyo ................................................................ I.2, I.11Hernandez Patricia ...................................................................................P1.18Hernández-Carlos Beatriz .................................................................... P1.07Hernandez-Pedro Norma .....................................................................P1.20Hirai Kyoji ...............................................................................................PD1.04Hirsch Fred ........................................................................................I.17, O.04Hochmair Maximilian J. ........................................O.03, PD2.02, PD2.05Hofman Paul ......................................................................................... P1.08-AHolzhausen Allison .............................................................................PD2.04Hong David S ........................................................................................P2.15-CHorn Leora .................................................................................O.02, PD2.04Hossein Borghaei .....................................................................................O.02

Howell Kristin .............................................................................................O.04Hui Rina .......................................................................................O.03, PD2.02Hunis Brian..................................................................P2.21, PD1.06, PD2.01

IIotti Alejandro ..............................................................................................P1.11Iriarte Maria B. ...........................................................................................P2.18Isla Dolores ............................................................................................... P2.02Iyengar Puneeth ..........................................................................................I.16Izquierdo Paola ........................................................................................ P2.21

JJaimes Yolanda .....................................................................................PD2.01Jauk Federico ............................................................................................ P1.19Jennens Ross R. ...................................................................................PD2.02Jian Hong .................................................................................................. P2.02

KKaen Diego ................................................................................................ P2.21Kaushal Sunjay ...........................................................................................P1.17Kazakova Ekaterina ...............................................................................P2.04Kerr Keith ....................................................................................................O.04Kim Edward ................................................................................................O.04Kloecker Goetz .................................................................................... PD1.02Korbenfeld Erneston ..........................................................................P2.15-AKrauss John C .......................................................................................P2.15-CKumar Rohit ...........................................................................................PD1.02Kuo James C .........................................................................................P2.15-CKurata Takayasu .......................................................................O.03, PD2.02

LLabanca María José ...................................................................................P1.11Laguado Paola ...........................................................................P2.23, P2.25Landi Maria Teresa ............................................................................. P1.08-ALantuejoul Sylvie ......................................................................................O.04Lazaro Miguel ..........................................................................................P2.04Leal Ticiana ........................................................................................... PD2.04Lee Ki Hyeong ......................................................................................... P2.02Legarda Emily........................................................................................... P1.23Leguina Laura ..............................................................................................P1.11Leticia Solano Nieto Alma ........................................................ P1.16, P2.17Li Ang ...........................................................................................................O.02Li Bob T ...................................................................................................P2.15-CLi Hsin ..........................................................................................................P1.09Lira-De León Karla Isabel ........................................................ P1.06, P1.07Li Wei .......................................................................................................... P2.02Lopes Gilberto .............................................................................P2.06, P2.21Lopez Diego ............................................................................................. P2.24Lopez-Bigas Nuria ............................................................................. P1.08-ALópez Reséndiz Karina Elyane ...................................P1.01, P1.02, P1.03Lores Juliana ............................................................................................. P2.16Lozano Sophia ................................................................................ P1.10, P1.12Lupinacci Lorena .......................................................................P2.23, P2.25Lu Shun ...................................................................................................... P2.02

MMadureira Rosa .........................................................................................P2.15Maldini C .................................................................................................P2.15-BMaquera Grisnery ...................................................................................P2.05Marcelo Horacio ...................................................................................P2.15-AMareco Karen ...........................................................................................P2.09Marmolejo Torres Maria Esther ......................................................P1.16-AMärten Angela ......................................................................................PD2.05Martín Claudio .......................PD1.05, P1.10, P1.12, P2.03, P2.22, P2.23, ....................................................................P2.25, P2.15-A, PD2.03, PD2.06Martinez Herrera Jose Fabian ............................................................ P2.14Martín María Eugenia ................................................................................P1.11Mas Luis ...................... PD1.05, P1.10, P1.12, P2.01, P2.05, P2.21, P2.22,....................................................................... P2.23, P2.25, PD2.03, PD2.06Mathias Clarissa ............................................................................... I.21, O.04Mayorga Diana ................PD1.05, P1.10, P1.12, P2.22, PD2.03, PD2.06

Author Index

LALCA2019.IASLC.ORG

31


31

AU

THO

R IN

DE

X

Mccusker Michael ......................................................................................O.01Mehra Ranee ...............................................................................................O.01Mendez Alejandra ...................................................................................P2.13Mendoza Laura ....................................................................................P1.08-A Meneses-García Antelmo Abelardo ................................................ P2.26Meraz-Ríos Marco Antonio ..................................................... P1.06, P1.07Midence Arguello Maria Jose ..............................................................P2.17Minatta Jose Nicolás ............................................................................... P1.19Min Young J. ............................................................................................. P2.02Miranda Yesenia ......................................................................................P2.05Molina Matias ..............................................................................................P1.18Montella Tatiane ..........................................................................P1.26, P2.07Morabito Alessandro ............................................................ P2.02, PD2.05Morales Eliana I. ......................................P1.22, P1.24, P1.25, P2.18, P2.19Mora María Florencia ................................................................................P1.11Moreira Gisele ...........................................................................................P1.26Moreno Joan ............................................................................................P2.05Morrow Phuong Khanh .....................................................................P2.15-CMota Beatriz ............................................................................................. P2.24Munoz Antonia Teresita ........................................................................ P2.21

NNajera Ramirez Rubisela........................................................................P2.17Neal Joel W............................................................................................PD2.04Ngang Jude ...........................................................................................P2.15-CNgarmchamnanrith Gataree ...........................................................P2.15-CNovello Silvia.........................................................................................PD2.02Nuñez German ................................................................................... I.1-1, I.1-2

OOfonakara Uzochukwu ......................................................................... P1.04Olivera Mivael ..........................................................................................P2.05Olmedo Gloria .............................................................................................P1.11Orellana Eric ..........................................................................................P2.15-AOrlandi Francisco ................................................................................P2.15-AOrozco-Morales Mario .......................................................................... P1.20Ortega Leandro Nahuel ......................................................................... P1.19Ortíz Carlos .................................................................................P2.23, P2.25Otero Jorge ..........................................PD1.05, P1.10, P1.12, P2.22, P2.23, ..................................................................................... P2.25, PD2.03, PD2.06Otterson Gregory .....................................................................................O.02Oxnard Geoffrey R. .............................................................................PD2.04

PPacheco-Cuellar Guillermo .............................................................. PD1.03Paladio Hernández José Ángel ......................................................... P2.26Palafox Torres David Isai ..................................................................... P2.26Paradelo Martin ..........................................................................................P1.18Patane Ana Karina ........................................................................ P1.10, P1.12Patel Sandip P. ......................................................................................PD2.04Peikert Tobias ...................................................................................... P1.08-APeled Nir .....................................................................................O.03, PD2.02Peña Gomez Portugal Emmanuel .........................................P1.16, P2.17Penrod Jonh R ...........................................................................................O.02Peralta Álvarez Marco Polo ..................................... P2.03, P2.24, P2.26Perazzo Florencia......................................................................P2.23, P2.25Pereira-García Ariana ...........................................................................P2.03Peres Wilza ............................................................................................... P2.07Perez Alejandro ......................................................................................P2.09Perez Bladimir ...........................................................................................P2.18Perez Mario .......................................................................................... I.1-1, I.1-2Pérez-Ramírez Iza Fernanda ...............................................................P1.06Perikleous Periklis ....................................................................................P1.21Perroud Hernan ....................................................................................P2.15-APichardo Meneses Ofelia .......................................................................P2.17Pietanza M. Catherine ............................................................O.03, PD2.02Piñeiro Natalia .........................................................................................P2.09Pilnik Norma ......................................................................................... P2.15-BPino Luis Eduardo .....................................................................P2.23, P2.25Pintelon Isabel ............................................................................................P1.17Planchard David........................................................................................O.02Pluzanski Adam ........................................................................................O.02Poleri Claudia ..............................................................................................P1.11

Porras Gutiérrez Rebeca .......................................................................P2.13Postmus Pieter ..........................................................................................O.04Powell Charles ...........................................................................................O.04Powell Steven ............................................................................................O.03Powell Steven F. ...................................................................................PD2.02Price Timothy J ....................................................................................P2.15-CPucci Marzia ................................................................................................P1.17Pupareli Carmen ........................................................................P2.23, P2.25

RRaez Luis E. ............I.13-1, I.18-1, P2.21, P2.23, P2.25, PD1.06, PD2.01Ramalingam Suresh.....................................................................O.02, O.04Ramirez Candelas Miguel Angel .........................................................P2.12Ramírez Tirado Laura Alejandra ......................................... P2.24, P2.26Rasmussen Erik ....................................................................................P2.15-CRayá Mercedes ............................................................................................P1.11Reckamp Karen L. ...............................................................................PD2.04Reck Martin................................................................................O.03, PD2.02Reclusa Pablo .............................................................................................P1.17Recondo Gonzalo................................................................................P2.15-AReginatto Atilio ...........................................................................................P1.11Reinhold Florencia ..............................................................................P2.15-ARemon Jordi .................................................................................... P1.10, P1.12Ricaurte Luisa ....... P1.10, P1.12, P2.22, P2.23, P2.25, PD2.03, PD2.06Richardet Eduardo ...................................................................................P1.18Richardet Martin ........................................................................................P1.18Richeimer Kristin ......................................................................................O.04Rioja Patricia ................................................................................... P1.10, P1.12Rivera Rivera Samuel ............................................................................P2.04Rizzo Manglio .............................................................................P2.23, P2.25Rodríguez-Abreu Delvys ..................................................... O.03, PD2.02Rodríguez July ....................................PD1.05, P1.10, P1.12, P2.22, P2.23, ..................................................................................... P2.25, PD2.03, PD2.06Rodriguez Palleiro Maria Clara ..........................................................P2.09Rojas Leonardo ..........................................................................P2.23, P2.25Rojas Victor ................................................................................. P2.01, P2.05Rolfo Christian Diego........................................O.01, P1.17, P2.23, P2.25Roque Katia ..............................................................................................P2.05Rosell Rafael ................................I.19, PD1.05, P1.10, P1.12, P2.22, P2.23, ..................................................................................... P2.25, PD2.03, PD2.06Rothberg Bonnie ................................................................................ P1.08-ARubio-Viqueira Belén .........................................................................PD2.02Ruiz-Godoy Luz María ..............................................................P1.20, P2.26Ruiz Mendoza Rossana ...........................................................P2.23, P2.25Ruiz-Patiño Alejandro ...................................PD1.05, P1.10, P1.12, P2.22, ........................................................................ P2.23, P2.25, PD2.03, PD2.06Ruiz Rossana .........................................................P1.10, P1.12, P2.05, P2.21Russo Alessandro ......................................................................................O.01

SSacramento Vânia .......................................................................P1.05, P2.15Salas-Coronado Raúl ............................................................................. P1.07Sanchez Garcia Ramos Emilio .............................................................P2.17Sánchez Reyes Roberto .......................................................................P2.03Sánchez Ríos Carla Paola ...........................................P2.10, P2.12, P2.14Sanchez Santiago ................................................................................... P1.24Santamaría Abel ......................................................................................P1.20Santos-Sánchez Norma Francenia ................................................... P1.07Saravia Diana ..............................................................................P2.06, P2.21Scagliotti Giorgio .....................................................................................O.04Schwarz Luis J. .........................................................................................P2.01Scilla Katherine A. .....................................................................................O.01Selvaggi Giovanni................................................................................PD2.04Sena Susana ..........................................................................................P2.15-AShin Dong Wook ...................................................................................PD1.01Silva Alejandro ........................................................................................P2.04Smeltzer Matthew ....................................................................................O.04Soong Deborah .......................................................................................P2.06Soo Ross A. ...............................................................................O.04, PD2.05Soria Tannia ..................................................................................... P1.10, P1.12Sotelo Carolina ....................................PD1.05, P1.10, P1.12, P2.22, P2.23, ..................................................................................... P2.25, PD2.03, PD2.06Sowley Taysser ............................................................................P1.13, P2.08Speranza Giovanna .................................................................O.03, PD2.02

PRESENTATIONS HIGHLIGHTED IN BOLD = PRESENTING AUTHOR FOR THIS ABSTRACT


32

AU

THO

R IN

DE

X

Strickler John H ...................................................................................P2.15-CSua Luz.............................. P1.22, P1.23, P1.24, P1.25, P2.16, P2.18, P2.19Sumarriva Daniel ......................................................................P2.21, PD2.01Syrigos Konstantinos ............................................................................ P2.02

TTanny Sean.................................................................................................P1.09Taverna Simona ..........................................................................................P1.17Taylor Meghan ...........................................................................................O.04Thibodeau Ryan .......................................................................................P1.09Tsuboi Masahiro ........................................................................................O.04Turcott Jenny ................................................................................................. I.5

UUgalde-Villanueva Brenda ...................................................................P1.06Usher Joshua .........................................................................................PD2.01Usuda Jitsuo ..........................................................................................PD1.04

VValdéz-Andrade Juan Jesús .............................................................PD1.03Valdivieso Natalia ...................................................................................P2.05Varela Santoyo Edgar ...........................................................................P2.03Vargas Carlos .......................................PD1.05, P1.10, P1.12, P2.22, P2.23, ..................................................................................... P2.25, PD2.03, PD2.06Varella-Garcia, Marileila ............................................................................I.13Vasconcellos Juliana .................................................................P1.26, P2.07Vega-Rodríguez Ana Laura ................................................................. P1.07Vela Nieto Miryana Perez .......................................................................... I.8Velasquez Mauricio .....................................................................P1.24, P2.18Verstraelen Peter .......................................................................................P1.17Vilches Cisneros Natalia ...............................................P1.01, P1.02, P1.03Villa Antonio .............................................................................................P2.04

WWakelee Heather ........................................................................I.21, PD2.04Wang Lara ..............................................................................................PD2.05Waqar Saiama N. .................................................................................PD2.04Wedge David ....................................................................................... P1.08-AWerbach Andrea ........................................................................................P1.11William William ...........................................................................................I.22Wistuba Ignacio ............................................................................I.12-1, O.04Wojcik-Tomaszewska Joanna ..............................................................O.02Wood Kelsey ..............................................................................................O.04Wynes Murry ..............................................................................................O.04

YYang Cheng-Ta .....................................................................................PD2.05Yang James C-H ..................................................................................PD2.05Yang Jing ....................................................................................O.03, PD2.02Yu Yongfeng ............................................................................................. P2.02

ZZapata Marcos ......................................................................................P2.15-AZatarain Barron Lucia ....................................PD1.05, P1.10, P1.12, P2.03, ................................P2.22, P2.23, P2.24, P2.25, P2.26, PD2.03, PD2.06Zavala Retes Benjamin ...........................................................................P1.14Zervino Ignacio ..............................................................................................I.7Zhang Tongwu .................................................................................... P1.08-AZhang Yu ................................................................................................... P1.08Zhou Joey ..............................................................................................PD2.04Zimmermann, Camilla ................................................................................ I.6Zuloaga Carlos ........................................................................................P2.04

Author Index PRESENTATIONS HIGHLIGHTED IN BOLD = PRESENTING AUTHOR FOR THIS ABSTRACT

LUNG CANCER NEWSThe IASLC Lung Cancer News, the IASLC’s bi-monthly newspaper, features the latest information on lung cancer research, patient care, tobacco control, expert commentary from lung cancer thought leaders around the world and more.

Look for the IASLC Lung Cancer News in your delegate bag or pick up a copy at the IASLC Booth in the Exhibit Hall.

LungCancerNews.org

INTERNATIONALASSOCIATION FOR THE STUDY OF LUNG CANCER Conquering Thoracic Cancers Worldwide

THIS IS A MEMBER BENEFIT!

LALCA2019.IASLC.ORG

33


33

GE

NE

RA

L CO

NFE

RE

NC

E IN

FOR

MA

TION

JTO Impact Factor

increases to

12.460!Ranked 10th among 229

oncology journals.

Ranked 3rd among 63 respiratory medicine

journals

JTO is the #1 journal focused on disseminating research and therapy of thoracic malignancies,

according to Editor-in-Chief, Alex A. Adjei, MD, PhD

Two things to note about reported IFs: 1) the IF is reported for the previous year (2018 IF is reported

in 2019) and 2) the IF is always reported to the third decimal point, even if it is a zero


34

IASLC 2020Meetings Schedule

Sixth AACR-IASLC International Joint Conference: Lung Cancer

January 11-14, 2020 | San Diego, CA | #Lung20

IASLC 2020 Targeted Therapies of Lung Cancer

February 19-22, 2020 | Santa Monica, CA #TTLC20

European Lung Cancer Congress 2020

April 15-18, 2020 | Geneva, Switzerland #ELCC20

Lung Cancer Hot Topic: Liquid Biopsy

May 2020

IASLC 2020 World Conference on Lung Cancer

August 9-12, 2020 | Singapore | #WCLC20

IASLC 2020 North America Conference on Lung CancerOctober 15-17, 2020 | Chicago, IL

#NACLC20

Lung Cancer Hot Topic: Immunotherapy

November 2020

LALCA2019.IASLC.ORG

35


35

HOPELIVES

Help us fight stigma and spread HOPE! Whether you are a patient, caregiver, advocate or

physician, YOU can take action to contribute to Lung Cancer Awareness Month.

Additional support by independent educational grants from Takeda and AstraZeneca The IASLC is a proud partner of the LCAM Coalition

How to spread HOPEShare or download resources: LCAM.org/resources | LCAM.org/share-your-story

Connect on social media:

Visit the IASLC booth in the Exhibit Hall to learn more!www.facebook.com/LCAM.org/ @LCAM_org

#LCAM

MORE RESEARCH. MORE SURVIVORS.

The LCAM Coalition is supported by over 40 partner organizations from around the world. Key focus topics:

• Clinical Trials• Precision Medicine

• Screening & Early Detection• Advocacy

#WCLC20www.iaslc.org

@IASLC

facebook.com/IASLC

iaslc.lung

Documents

IASLC 2019 Latin America Conference on Lung Cancer (LALCA … · 2019-10-12 · LALCA2019.IASLC.ORG 3 IASLC 2019 Latin America Conference on Lung Cancer (LALCA 2019) | Final Scientiffc